Stopped: Interim analysis at 50% of planned enrollment met prespecified critieria.
The purpose of this clinical study is to compare how well two different devices for achieving hemostasis perform in patients undergoing transradial procedures. Both devices are approved by the FDA for this use, and have already been used by clinicians on patients undergoing transradial procedures. It is believed that the use of both devices in combination compared to the hemostasis band (TR band) alone will shorten the time that it takes to 'seal' the artery, resulting in a shorter period of time that you would need to wear the hemostasis band.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Time to Hemostasis Using the Hemostasis Management System (HMS)
Timeframe: Within 30 minutes of discharge or 24 hours post procedure (± 1 hour), whichever occurs first.